Abacus Finance Group, a New York-based direct lending company that provides cash-flow senior financing for private equity-sponsored, lower-middle market companies, announced it served as administrative agent and lead arranger for a senior secured credit facility to support the acquisition of Biochemical Diagnostics by Kova International (Kova).

Kova is backed by an investor group that includes One Rock Capital Partners, Laurel Crown Partners, StoneCreek Capital and management.

Garden Grove, CA-based Kova is a developer, manufacturer, and marketer of in-vitro diagnostic products for the global urinalysis market.

Edgewood, NY-based Biochemical Diagnostics is a manufacturer and marketer of controls and disposable sample preparation products used in drugs of abuse testing.